Company: EVLVW
Filing Date: 2025-03-31
Form Type: NT 10-K
Source: 0001104659-25-029637
Chunk: 3

Company: Evolv Technologies Holdings, Inc.
Filing Date: 2025-03-31
Form: NT 10-K
Chunk 3
---
daq Stock Market (“Nasdaq”) on January 31, 2025, informing the Company that Nasdaq has granted the Company’s
request for an exception to Nasdaq’s Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic
financial reports with the SEC. Pursuant to the exception, the Company has until May 19, 2025 to timely file any delinquent required periodic
financial reports with the SEC. In conjunction with the filing of the Form 10-K, the Company also expects to file its Quarterly Report
on Form 10-Q for the quarterly period ended September 30, 2024 (the “Form 10-Q”). The Company expects to be current with all
its SEC filing requirements no later than May 19, 2025.

<div align='center'>PART IV

OTHER INFORMATION</div>

(1) Name and telephone number of person to contact
in regard to this notification

| Rachel Roy |     |        781 |     | 374-8100          |
| (Name)     |     | -Area Code |     | -Telephone Number |

(2) Have all other periodic reports required under
Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12
months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).

¨ Yesx
No Quarterly Report on Form 10-Q for the period ended September 30, 2024.

(3) Is it anticipated that any significant change
in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included
in the subject report or portion thereof?

x Yes¨
No

If so, attach an explanation of the anticipated
change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be
made.

The Company is actively working to prepare amendments
to its financial statements and related filings addressing the misstatements described in Part III and complete its financial statements
for the fiscal year ended December 31, 2024. Until the restatements of the prior periods described in Part III are finalized,
the Company is unable to reasonably estimate the anticipated changes in results of operations for the period ended December 31, 2024.

As of